titlesubmit dateissue date
Now showing items 1-12 of 12
A mutation in the POT1 gene is responsible for cardiac angiosarcoma in
TP53-negative Li-Fraumeni-like families
Activation of Serine One-Carbon Metabolism by Calcineurin A beta 1 Reduces Myocardial Hypertrophy and Improves Ventricular Function
Animal models of arrhythmogenic right ventricular cardiomyopathy: what have we learned and where do we go? Insight for therapeutics
Design of the β3-Adrenergic Agonist Treatment in Chronic Pulmonary Hypertension Secondary to Heart Failure Trial.
Genetic Etiology for Alcohol-Induced Cardiac Toxicity
Genetic Variants Associated With Cancer Therapy-Induced Cardiomyopathy
Genetically Confirmed Familial Hypercholesterolemia in Patients With Acute Coronary Syndrome
Identification of a peripheral blood gene signature predicting aortic valve calcification.
Infective endocarditis in hypertrophic cardiomyopathy: A multicenter, prospective, cohort study
Lafora Disease Is an Inherited Metabolic Cardiomyopathy
POT1 and Damage Response Malfunction Trigger Acquisition of Somatic Activating Mutations in the VEGF Pathway in Cardiac Angiosarcomas
Severe Cardiac Dysfunction and Death Caused by Arrhythmogenic Right Ventricular Cardiomyopathy Type 5 Are Improved by Inhibition of Glycogen Synthase Kinase-3β